Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -1.45EBITDA per Share
VS
Market
Sector
Industry
History
$ 2.37Close
$ 1.1 - $ 6.45 52-Week Range
Ticker Information
Ticker
CCCCCompany Name
C4 THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQC4 THERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CCCC - EBITDAPS Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -102.89M | $ -1.45 | 1 | 71.01M |
| 3/31/2025 | $ -94.83M | $ -1.34 | 1 | 70.83M |
| 12/31/2024 | $ -96.95M | $ -1.4 | 1 | 69.37M |
| 9/30/2024 | $ -97.1M | $ -1.39 | 1 | 69.63M |
| 6/30/2024 | $ -98.36M | $ -1.43 | 1 | 68.81M |
| 3/31/2024 | $ -116.02M | $ -1.7 | 1 | 68.43M |
| 12/31/2023 | $ -121.8M | $ -2.45 | 1 | 49.64M |
| 9/30/2023 | $ -123.88M | $ -2.52 | 1 | 49.21M |
| 6/30/2023 | $ -129.49M | $ -2.64 | 1 | 49.06M |
| 3/31/2023 | $ -120.89M | $ -2.47 | 1 | 49.03M |
Key Performance Insights, Last 5 Years
- C4 THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ 0.
- Over the past 5 years, C4 THERAPEUTICS INC's average EBITDAPS has been $ -2.1.
- The median EBITDAPS for C4 THERAPEUTICS INC during this period was $ -1.85
- C4 THERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ -1.34.
- The lowest EBITDAPS recorded by C4 THERAPEUTICS INC in the same timeframe $ -5.53
C4 THERAPEUTICS INC's EBITDAPS vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDAPS Benchmarks
Similar metrics to Shares WA:
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBITDA per Share
[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for C4 THERAPEUTICS INC is calculated as follows: EBITDA [ $ 0 ] / (Shares WA [ 1.54M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ 0 ] CCCC - EBITDA per Share, Last 5 years
$ -5.53
Minimum
Dec 31, 2020
$ -1.34
Maximum
Mar 31, 2025
$ -2.1
Average
$ -1.85
Median
EBITDAPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
| filtered constituents | 3.78K |
|---|---|
| min | $ -10.86 |
| max | $ 13.95 |
| average | $ 2.01 |
| median | $ 0.99 |
| std | $ 4.26 |